La Jolla Backtesting

LJPC -- USA Stock  

USD 10.28  0.53  4.90%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of La Jolla Pharmaceutical Company and determine expected loss or profit from investing in La Jolla over given investment horizon. Please see also La Jolla Hype Analysis, La Jolla Correlation, La Jolla Valuation, La Jolla Volatility as well as analyze La Jolla Alpha and Beta and La Jolla Performance.
Horizon     30 Days    Login   to change

La Jolla 'What if' Analysis

June 21, 2019
No Change 0.00  0.0%
In 3 months and 1 day
September 19, 2019
If you would invest  0.00  in La Jolla on June 21, 2019 and sell it all today you would earn a total of 0.00 from holding La Jolla Pharmaceutical Company or generate 0.0% return on investment in La Jolla over 90 days. La Jolla is related to or competes with Dynavax Technologies, Dova Pharmaceuticals, NantKwest, Global Cord, DiaMedica Therapeutics, Auris Medical, and Dicerna Pharmaceuticals. La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercializati...

La Jolla Upside/Downside Indicators

Downside Deviation3.21
Information Ratio0.0285
Maximum Drawdown12.43
Value At Risk(4.90)
Potential Upside5.27

La Jolla Market Premium Indicators

Risk Adjusted Performance0.0438
Jensen Alpha0.1089
Total Risk Alpha0.015
Sortino Ratio0.0282
Treynor Ratio0.3195

La Jolla Pharmaceutical Backtested Returns

Macroaxis considers La Jolla slightly risky given 3 months investment horizon. La Jolla Pharmaceutical retains Efficiency (Sharpe Ratio) of 0.0998 which conveys that the firm had 0.0998% of return per unit of price deviation over the last 3 months. Our approach towards estimating volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for La Jolla which you can use to evaluate future volatility of the firm. Please exercise La Jolla Pharmaceutical Company Market Risk Adjusted Performance of 0.3295, Mean Deviation of 2.5 and Standard Deviation of 3.18 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100 La Jolla holds performance score of 6. The company owns Beta (Systematic Risk) of 0.3756 which conveys that as returns on market increase, La Jolla returns are expected to increase less than the market. However during bear market, the loss on holding La Jolla will be expected to be smaller as well. Although it is vital to follow to La Jolla Pharmaceutical existing price patterns, it is good to be conservative about what you can actually do with the information regarding equity price patterns. The approach towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By reviewing La Jolla Pharmaceutical technical indicators you can at this time evaluate if the expected return of 0.3004% will be sustainable into the future. Please exercises La Jolla Pharmaceutical Company Jensen Alpha, and the relationship between Coefficient Of Variation and Potential Upside to make a quick decision on weather La Jolla Pharmaceutical current price history will revert.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation(0.14) 
correlation synergy

Insignificant reverse predictability

La Jolla Pharmaceutical Company has insignificant reverse predictability. Overlapping area represents the amount of predictability between La Jolla time series from June 21, 2019 to August 5, 2019 and August 5, 2019 to September 19, 2019. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of La Jolla Pharmaceutical price movement. The serial correlation of -0.14 indicates that less than 14.0% of current La Jolla price fluctuation can be explain by its past prices. Given that La Jolla Pharmaceutical Company has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of La Jolla for similar time interval.
Correlation Coefficient-0.14
Spearman Rank Test-0.21
Residual Average0.0
Price Variance0.64

La Jolla Pharmaceutical lagged returns against current returns

 Current and Lagged Values 

La Jolla regressed lagged prices vs. current prices

 Current vs Lagged Prices 

La Jolla Lagged Returns

 Regressed Prices 

Current Sentiment - LJPC

La Jolla Pharmaceutical Investor Sentiment

Most of Macroaxis users are now bullish on La Jolla Pharmaceutical Company. What is your trading attitude regarding investing in La Jolla Pharmaceutical Company? Are you bullish or bearish?
98% Bullish
2% Bearish

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also La Jolla Hype Analysis, La Jolla Correlation, La Jolla Valuation, La Jolla Volatility as well as analyze La Jolla Alpha and Beta and La Jolla Performance. Please also try Financial Widgets module to easily integrated macroaxis content with over 30 different plug-and-play financial widgets.